B Egestad
Impact in
- Clinical Biochemistry top 2%
- Metabolism and Genetic Disorders
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Metabolism and Genetic Disorders 6
- Oncology 10
- Drug Transport and Resistance Mechanisms 10
- Co-authors
- Jan Sjövall (15 shared papers)Peter Theodore Clayton (4 shared papers)S Matern (4 shared papers)Heidrun MATERN (4 shared papers)Hanns–Ulrich Marschall (4 shared papers)A. M. Lawson (2 shared papers)Stig Andersson (2 shared papers)J V Leonard (1 shared paper)
- Journals
- Journal of Lipid Research (4 papers)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)Xenobiotica (1 paper)Journal of Mass Spectrometry (1 paper)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
B Egestad
20 papers receiving 808 citations
Peers
Comparison fields: 5 of 81
- Clinical Biochemistry 199
- Oncology 456
- Pharmacology 113
- Behavioral Neuroscience 25
- Surgery 260
Countries citing papers authored by B Egestad
This map shows the geographic impact of B Egestad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Egestad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Egestad more than expected).
Fields of papers citing papers by B Egestad
This network shows the impact of papers produced by B Egestad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Egestad. The network helps show where B Egestad may publish in the future.
Co-authors
The 25 scholars most cited alongside B Egestad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 172 | |
| 2 | 1992 | 88 | |
| 3 | 1988 | 82 | |
| 4 | 1991 | 82 | |
| 5 | 1992 | 64 | |
| 6 | Familial giant cell hepatitis associated with synthesis of 3β,7α-dihydroxy- and 3β,7α,12α-trihydroxy-5-cholenoic acid | 1987 | 51 |
| 7 | 1989 | 49 | |
| 8 | 1987 | 47 | |
| 9 | 1987 | 40 | |
| 10 | 1989 | 40 | |
| 11 | 1987 | 37 | |
| 12 | 1989 | 24 | |
| 13 | Identification and determination of phenylacetylglutamine, a major nitrogenous metabolite in plasma of uremic patients. | 1989 | 20 |
| 14 | 1986 | 19 | |
| 15 | 1996 | 15 | |
| 16 | 1982 | 14 | |
| 17 | 1994 | 10 | |
| 18 | 1983 | 8 | |
| 19 | 1992 | 6 | |
| 20 | 1988 | 3 |
About B Egestad
B Egestad is a scholar working on Clinical Biochemistry, Oncology, Health, Toxicology and Mutagenesis, Pharmacology and Pharmaceutical Science, having authored 20 papers that have together received 871 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (10 papers), Metabolism and Genetic Disorders (6 papers), Effects and risks of endocrine disrupting chemicals (3 papers), Chemical Reactions and Isotopes (2 papers), Analytical Chemistry and Chromatography (2 papers), Aldose Reductase and Taurine (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Pharmacogenetics and Drug Metabolism (2 papers). The work is most often cited by research in Clinical Biochemistry (199 citations), Oncology (456 citations), Pharmacology (113 citations), Behavioral Neuroscience (25 citations) and Surgery (260 citations). B Egestad has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Jan Sjövall, Peter Theodore Clayton, S Matern, Heidrun MATERN, Hanns–Ulrich Marschall, A. M. Lawson, Stig Andersson, J V Leonard, Kenneth D.R. Setchell and Birgitta Strandvik. Their work appears in journals such as Journal of Lipid Research, Journal of Biological Chemistry, Journal of Clinical Investigation, Xenobiotica and Journal of Mass Spectrometry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.